Welcome to our dedicated page for Caci Intl SEC filings (Ticker: CACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CACI International Inc filings document the formal disclosures of an operating national security technology company serving U.S. government defense, intelligence and federal civilian customers. Recent Form 8-K reports cover fiscal-quarter results, financial-condition disclosures, material agreements and exhibits tied to the company's operating performance and contract-driven business.
The filing record also documents capital-structure actions, including unsecured senior notes due 2033, related subsidiary guarantees and financing arrangements connected to the completed ARKA Group acquisition. Other disclosures address accounts receivable purchase arrangements, board composition, director independence, compensatory arrangements and other governance matters reported under current-report requirements.
John S. Mengucci, President & CEO and director of CACI International, Inc. (CACI), reported multiple stock-based transactions on 10/01/2025 on Form 4. The filing shows a mix of acquisitions and dispositions of common stock and the vesting/granting of restricted stock units (RSUs) and performance RSUs (PRSUs). Following the transactions, Mr. Mengucci beneficially owned between 103,884 and 128,827 shares across the reported lines depending on each transaction line's cumulative totals. The report records vested and newly granted awards: 12,618 PRSUs and 12,617 RSUs granted on 10/01/2025, plus earlier grants from 2022–2024 with specified vesting schedules. Several disposition entries list a price of $515.16 per share. The filing is a routine insider report documenting compensation-related equity grants and related share movements.
DeEtte Gray, President, US Operations of CACI, reported transactions dated 10/01/2025 on a Form 4. The filing shows multiple restricted stock unit and performance restricted stock unit grants and vesting events: prior grants from 10/01/2022, 10/01/2023, and 10/01/2024 are described, and new grants on 10/01/2025 include 2,233 performance RSUs and 2,232 restricted stock units. The Form 4 also records a series of non-derivative transactions on the same date including dispositions executed at a reported price of $515.16. The tables list changing beneficial ownership totals after each reported event for CACI common stock. The signature date on the form is 10/03/2025.
Tracy Weir, Chief Executive Officer, UK of CACI International Inc. (CACI), reported multiple transactions dated 10/01/2025. The Form 4 shows grants of 291 restricted stock units and 292 performance restricted stock units (total 583 units) granted on that date; the PRSUs vest on the third anniversary subject to a three‑year performance measure and the RSUs vest one‑third per year over three years. The filing also records multiple dispositions totaling 413 shares sold at $515.16 per share, and changes in beneficial ownership levels reported after each transaction. The report is a routine insider filing documenting equity awards and share sales by an executive.
J. William Koegel Jr., EVP & General Counsel of CACI (CACI) reported multiple transactions dated 10/01/2025. The filing shows the vesting/acquisition of 4,442 common shares through restricted stock units and performance restricted stock units and the grant of 971 additional restricted stock units plus 971 performance restricted stock units. Concurrently, the report discloses dispositions of 2,101 common shares at $515.16 per share. After these transactions, Mr. Koegel beneficially owned 27,931 shares of CACI common stock, held directly.
Eric Blazer, Senior Vice President, Corporate Controller & Chief Accounting Officer of CACI International, Inc. (CACI), reported equity awards and transactions on a Form 4. On 10/01/2025 he received 194 restricted stock units (RSUs) and 195 performance restricted stock units (PRSUs); the PRSUs vest on the third anniversary based on a three‑year performance measure. The report also records earlier entries: a 65-share grant coded as M and an earlier 198 RSU grant dated 10/01/2024 that vests one‑third per year for three years. Following the transactions reported, Mr. Blazer beneficially owns reported totals of 132, 112, and derivative holdings of 194, 195, and 133 shares in the classes listed. The Form is signed 10/03/2025.
Insider sale by CEO and director John S. Mengucci: The Form 4 shows Mr. Mengucci sold 10,175 shares of CACI common stock on 09/15/2025 in multiple transactions at weighted-average prices ranging roughly from $490.29 to $493.96 per share. After these disposals his reported beneficial ownership declined from 111,678 shares to 101,536 shares.
The filing lists Mr. Mengucci as both President & CEO and a director and provides transaction-level price ranges for each grouped sale. No derivative transactions or other compensatory grants are reported in this Form 4. The form is signed by the reporting person on 09/16/2025.
Insider sale by CEO and director John S. Mengucci: The Form 4 shows Mr. Mengucci sold 10,175 shares of CACI common stock on 09/15/2025 in multiple transactions at weighted-average prices ranging roughly from $490.29 to $493.96 per share. After these disposals his reported beneficial ownership declined from 111,678 shares to 101,536 shares.
The filing lists Mr. Mengucci as both President & CEO and a director and provides transaction-level price ranges for each grouped sale. No derivative transactions or other compensatory grants are reported in this Form 4. The form is signed by the reporting person on 09/16/2025.
Form 144 notice from an insider at CACI International Inc. (CACI) discloses a proposed sale of 10,175 shares of common stock, with an aggregate market value of $5,014,476, planned for 09/15/2025 on the NYSE. The filing shows the shares were acquired on 10/01/2024 through equity vesting: 7,115 shares from MSU vesting and 3,060 shares from RSU vesting issued by CACI International Inc. No securities of the issuer were reported sold by the filer in the past three months. The notice includes the filer’s certification that they are not aware of any undisclosed material adverse information about the issuer.
CACI International's definitive proxy describes governance, executive pay practices and a new equity plan for shareholder approval. The board is largely independent with 9 of 10 director nominees (90%) deemed independent. The company reports ~ $8.6 billion in annual revenue and 21,994,062 shares outstanding, with a closing share price of $479.72 on August 29, 2025. The Board approved the CACI International Inc. 2025 Incentive Compensation Plan, authorizing a base share reserve of 200,000 shares plus adjustments, and estimating overhang would rise from 5.35% to ~6.15% if approved; historical value-adjusted burn rates were 0.50% (2025), 0.87% (2024), and 0.81% (2023), averaging 0.72% over three years. The proxy details independent committee oversight of audit, compensation and governance, formal clawback policies, minimum vesting rules, change-in-control and severance provisions, and appointment of PricewaterhouseCoopers LLP as independent auditors for fiscal 2026. Shareholder votes on the 2025 Plan, ratification of auditors and advisory approval of executive compensation are described, with prior executive compensation approval exceeding 98% in 2024.
Tracy Weir, Chief Executive Officer, UK and director/officer of CACI International (CACI), had 268 restricted stock units vest on 08/22/2025, resulting in the acquisition of 268 shares under a reported transaction dated 08/22/2025 (transaction code M). After this transaction Ms. Weir beneficially owned 3,187 shares of CACI common stock. The filing indicates the RSUs were originally granted on 08/22/2022 under the Management Stock Purchase Plan and vested on the third anniversary of the grant. The Form 4 was signed by Tracy Weir on 08/26/2025.